Dose-response: Exercise Therapy on Hip Osteoarthritis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01700933 |
Recruitment Status
:
Completed
First Posted
: October 4, 2012
Last Update Posted
: September 21, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Osteoarthritis is a common disease that causes muscle weakness, stiffness and instability. The disease reduces the opportunities for an active lifestyle. Exercise Therapy provides a well-documented effect on pain and function in patients with osteoarthritis of the hip. It is sought an optimal dose of exercise, in which this study will help to investigate.
We hypothesize that an exercise program designed to have a high number of repetitions will benefit the outcome of the training in a more positive way than a low-repetition based program.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Osteoarthritis, Hip | Other: High-Dosage Exercise Therapy Other: Low-Dosage Exercise Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 35 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study |
Actual Study Start Date : | September 2012 |
Actual Primary Completion Date : | December 2014 |
Actual Study Completion Date : | December 2014 |

Arm | Intervention/treatment |
---|---|
Active Comparator: High-dosage-group |
Other: High-Dosage Exercise Therapy
Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) |
Active Comparator: Low-dosage-group |
Other: Low-Dosage Exercise Therapy
Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) |
- WOMAC Index of Osteoarthritis (questionnaire) [ Time Frame: 0 weeks, 8 weeks, 6 months postinterventional ]WOMAC Index of Osteoarthritis (questionnaire)
- HAD questionnaire [ Time Frame: 0 weeks, 8 weeks, 6 months postinterventional ]
- Tampa Scale for Kinesiophobia [ Time Frame: 0 weeks, 8 weeks, 6 months postinterventional ]
- Squats [ Time Frame: 0 weeks, 8 weeks, 6 months postinterventional ]Number of squats completed in 30 seconds.
- Stairs [ Time Frame: 0 weeks, 8 weeks, 6 months postinterventional ]Time used to walk up and down 12 steps.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 45 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- At least three month since debut of the disease
- Age above 45 years
- Ability to complete the intervention
Exclusion Criteria:
- Pain above 4 on VAS during gait
- Pregnancy
- Autoimmune disease
- Cardiovascular disease
- Respiratory disease
- Metabolic disease
- Neurological signs
- Planned hip-replacement surgery within the next year
- Received exercise therapy within the last 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700933
Norway | |
Fysioterapitjenesten i Ørsta | |
Ørsta, Norway, 6154 |
Principal Investigator: | Håvard Østerås | Norwegian University of Science and Technology |
Publications of Results:
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT01700933 History of Changes |
Other Study ID Numbers: |
DROAPS1 |
First Posted: | October 4, 2012 Key Record Dates |
Last Update Posted: | September 21, 2017 |
Last Verified: | September 2017 |
Studies a U.S. FDA-regulated Drug Product: | No | |
Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Norwegian University of Science and Technology:
Exercise therapy |
Additional relevant MeSH terms:
Osteoarthritis Osteoarthritis, Hip Arthritis |
Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |